▶ 調査レポート

世界のアンチエイジング治療市場(~2027):治療タイプ別、エンドユーザー別、流通チャネル別、地域別

• 英文タイトル:Anti-Ageing Treatment Market Research Report by Treatment Type, End User, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが調査・発行した産業分析レポートです。世界のアンチエイジング治療市場(~2027):治療タイプ別、エンドユーザー別、流通チャネル別、地域別 / Anti-Ageing Treatment Market Research Report by Treatment Type, End User, Distribution Channel, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 / MRC2305B151資料のイメージです。• レポートコード:MRC2305B151
• 出版社/出版日:360iResearch / 2022年10月
• レポート形態:英語、PDF、257ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥742,350 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,492,350 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社は、世界のアンチエイジング治療市場規模が2021年に435.9億ドル、2022年に456.8億ドルとなり、今後年平均4.96%拡大して2027年には582.9億ドルまで成長すると予測しています。当市場調査レポートは、アンチエイジング治療の世界市場を多面的に分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、治療タイプ別(腹部形成術、ニキビ治療、色素沈着防止、しわ防止トリートメント、まぶた手術)分析、エンドユーザー別(40歳以上、25歳以下、25~40歳)分析、流通チャネル別(病院&クリニック、高級サロン&スパ)分析、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)分析、競争状況、企業情報などの構成でまとめました。また、当書には、AbbVie, Inc、Alma Lasers Ltd、Bausch Health Companies Inc、Beiersdorf AG、Bo International、Carol Cole Company, Inc (NuFACE)、Clarins Group、Clinique Laboratories LLC、Coty Inc、Cynosure、DRAN Co. Ltd、Helix Biomedix、L'Occitane en Provenceなどの企業情報が含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト
・世界のアンチエイジング治療市場規模:治療タイプ別
- 腹部形成術の市場規模
- ニキビ治療の市場規模
- 色素沈着防止の市場規模
- しわ防止トリートメントの市場規模
- まぶた手術の市場規模
・世界のアンチエイジング治療市場規模:エンドユーザー別
- 40歳以上における市場規模
- 25歳以下における市場規模
- 25~40歳における市場規模
・世界のアンチエイジング治療市場規模:流通チャネル別
- 病院&クリニックにおける市場規模
- 高級サロン&スパにおける市場規模
・世界のアンチエイジング治療市場規模:地域別
- 南北アメリカのアンチエイジング治療市場規模
アメリカのアンチエイジング治療市場規模
カナダのアンチエイジング治療市場規模
ブラジルのアンチエイジング治療市場規模
...
- アジア太平洋のアンチエイジング治療市場規模
日本のアンチエイジング治療市場規模
中国のアンチエイジング治療市場規模
インドのアンチエイジング治療市場規模
韓国のアンチエイジング治療市場規模
台湾のアンチエイジング治療市場規模
...
- ヨーロッパ/中東/アフリカのアンチエイジング治療市場規模
イギリスのアンチエイジング治療市場規模
ドイツのアンチエイジング治療市場規模
フランスのアンチエイジング治療市場規模
ロシアのアンチエイジング治療市場規模
...
- その他地域のアンチエイジング治療市場規模
・競争状況
・企業情報

The Global Anti-Ageing Treatment Market size was estimated at USD 43.59 billion in 2021 and expected to reach USD 45.68 billion in 2022, and is projected to grow at a CAGR 4.96% to reach USD 58.29 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Anti-Ageing Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Treatment Type, the market was studied across Abdominoplasty, Acne Treatment, Anti-pigmentation, Anti-stretch Treatment, Anti-wrinkle Treatment, Chemical Peel, Eyelid Surgery, Hair Restoration, Liposuction Service, and Sclerotherapy.

Based on End User, the market was studied across 40 Years and above, Below 25 Years, and Between 25 and 40.

Based on Distribution Channel, the market was studied across Hospitals and Clinics and Luxury Salons and Spas.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Anti-Ageing Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Anti-Ageing Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Anti-Ageing Treatment Market, including AbbVie, Inc, Alma Lasers Ltd, Bausch Health Companies Inc, Beiersdorf AG, Bo International, Carol Cole Company, Inc (NuFACE), Clarins Group, Clinique Laboratories LLC, Coty Inc, Cynosure, DRAN Co. Ltd, Helix Biomedix, L’Occitane en Provence, Lumenis Ltd, L’Oreal SA, Ostium Cosmetics, Personal Microderm, Photomedex Inc, Prisil Life, Procter & Gamble Company, Shiseido Company, and Vichy Laboratories.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Anti-Ageing Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Anti-Ageing Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Anti-Ageing Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Anti-Ageing Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Anti-Ageing Treatment Market?
6. What is the market share of the leading vendors in the Global Anti-Ageing Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Anti-Ageing Treatment Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing geriatric population
5.1.1.2. Technological advancement in enhancement of human skin elasticity and tightness
5.1.1.3. Increased awareness of beauty in consumers worldwide
5.1.2. Restraints
5.1.2.1. High cost of anti-aging products
5.1.2.2. High possibility of side effects of products
5.1.3. Opportunities
5.1.3.1. High investment for research and development
5.1.3.2. Growing usage of anti-ageing treatment in developing regions
5.1.4. Challenges
5.1.4.1. Stringent government regulations for procedure and treatments
5.2. Cumulative Impact of COVID-19

6. Anti-Ageing Treatment Market, by Treatment Type
6.1. Introduction
6.2. Abdominoplasty
6.3. Acne Treatment
6.4. Anti-pigmentation
6.5. Anti-stretch Treatment
6.6. Anti-wrinkle Treatment
6.7. Chemical Peel
6.8. Eyelid Surgery
6.9. Hair Restoration
6.10. Liposuction Service
6.11. Sclerotherapy

7. Anti-Ageing Treatment Market, by End User
7.1. Introduction
7.2. 40 Years and above
7.3. Below 25 Years
7.4. Between 25 and 40

8. Anti-Ageing Treatment Market, by Distribution Channel
8.1. Introduction
8.2. Hospitals and Clinics
8.3. Luxury Salons and Spas

9. Americas Anti-Ageing Treatment Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Anti-Ageing Treatment Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Anti-Ageing Treatment Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. AbbVie, Inc
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Alma Lasers Ltd
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Bausch Health Companies Inc
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Beiersdorf AG
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Bo International
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Carol Cole Company, Inc (NuFACE)
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. Clarins Group
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Clinique Laboratories LLC
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Coty Inc
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Cynosure
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. DRAN Co. Ltd
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Helix Biomedix
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. L’Occitane en Provence
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Lumenis Ltd
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. L’Oreal SA
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services
13.16. Ostium Cosmetics
13.16.1. Business Overview
13.16.2. Key Executives
13.16.3. Product & Services
13.17. Personal Microderm
13.17.1. Business Overview
13.17.2. Key Executives
13.17.3. Product & Services
13.18. Photomedex Inc
13.18.1. Business Overview
13.18.2. Key Executives
13.18.3. Product & Services
13.19. Prisil Life
13.19.1. Business Overview
13.19.2. Key Executives
13.19.3. Product & Services
13.20. Procter & Gamble Company
13.20.1. Business Overview
13.20.2. Key Executives
13.20.3. Product & Services
13.21. Shiseido Company
13.21.1. Business Overview
13.21.2. Key Executives
13.21.3. Product & Services
13.22. Vichy Laboratories
13.22.1. Business Overview
13.22.2. Key Executives
13.22.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing